Flare‐up reactions in severe drug hypersensitivity: infection or ongoing T‐cell hyperresponsiveness

Publisher： John Wiley & Sons Inc

E-ISSN： 2050-0904|3|10|798-801

ISSN： 2050-0904

Source： Clinical Case Reports, Vol.3, Iss.10, 2015-10, pp. : 798-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Key Clinical Message“Flare‐up” reactions are late manifestations of severe T‐cell‐mediated drug hypersensitivity reactions. Management is anti‐inflammatory treatment and avoiding unnecessary medicines. Symptoms like fever, lymph node swelling, and blood count abnormalities may lead to confusion with bacterial infections. For prompt recognition it is important to keep the differential diagnosis in mind.

Related content

Oral Antifungal-Exacerbated Inflammatory Flare-Up Reactions of Dermatomycosis: Case Reports and Review of the Literature

By Nikkels Arjen F.   Nikkels-Tassoudji Nazli   Piérard Gérald E.  

American Journal of Clinical Dermatology, Vol. 7, Iss. 5, 2006-01 ,pp. : 327-331 (5)

Adis International

Access to resources Recommend Favorite

Neurocognitive decline in HIV patients is associated with ongoing T‐cell activation in the cerebrospinal fluid

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 9, 2015-09 ,pp. : 906-919 (14)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neurocognitive decline in HIV patients is associated with ongoing T‐cell activation in the cerebrospinal fluid

By  

Annals Of Clinical And Translational Neurology, Vol. 2328-9503, Iss. 9, 2015-09 ,pp. : 906-919 (14)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Romidepsin in the Treatment of T-Cell Lymphoma†: Profile Report

By Yang Lily P.H.  

BioDrugs, Vol. 25, Iss. 6, 2011-12 ,pp. : 393-395 (3)

Adis International

Access to resources Recommend Favorite

Successful treatment of immediate allogeneic myeloablative hematopoietic stem cell transplantation from a HLA‐mismatched sibling donor for active systemic epstein–barr virus‐positive T‐cell lymphoproliferative disease of childhood following primary acute epstein–barr virus infection

By  

Clinical Case Reports, Vol. 3, Iss. 4, 2015-04 ,pp. : 231-236 (6)

John Wiley & Sons Inc

Access to resources Recommend Favorite